Avantax Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
CIA
Avantax Advisory Services's RPRX Position: Q2 2025 in Review
Avantax Advisory Services increased its Royalty Pharma (RPRX) stake by 18% in Q2 2025, buying an estimated $79.3K and bringing the position to 15,793 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.
Avantax Advisory Services first reported a position in RPRX in Q2 2024 and has held it in 5 quarters since. 455 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.
- Avantax Advisory Services held 15,793 shares of Royalty Pharma worth $569K as of Q2 2025.
- Avantax Advisory Services bought 2,394 Royalty Pharma shares in Q2 2025, an estimated $79.3K.
- Royalty Pharma made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1508 holding.
- Avantax Advisory Services first reported a position in Royalty Pharma in Q2 2024 and has held it in 5 quarters since.
- 455 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.
Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.